Pharmaceutical listed companies are still the focus of institutional concern, continue to lead to institutional research

[
pharmacy network market analysis] Currently, the pharmaceutical industry performance is still strong, but also attracted institutions sustained attentionStatistics show that the information disclosed May 16 As of last week (May 11 to 15), including Jiangsu Guoxin, Zhongsheng Pharmaceutical, IFLYTEK, Yixintang, China and other information, including 127 listed companies We accept all kinds of research institutions, which traditional Chinese medicine, Western medicine and other pharmaceutical companies is still the focus of research institutionsSpecifically, the fertile Chinese medicine last week, Nakasone Pharmaceutical, Pharmaceutical beings, and easy to understand medicine, Xian Ju Pharmaceutical, Huangshan capsule and a number of pharmaceutical industry stocks access to institutional research attentionwhere Western medicine industry companies Xian Ju Pharmaceutical ushered GF Securities, joint research Huaxia Fund, BroadVision investment, Zhejiang nine chapters and information management, Tong source of investment, investment Jiu Peng, dozens of bodiesThe company said, the company from February 11 to return to work after another, has now fully resumed production complexSales, a quarterdrugoverall maintained a good growth, the end formulation affected to a certain extent, a quarter clinical use also was affectedAt present, except in some areas, most areas gradually restored to the good trendChinese listed companies to disclose Wo Chinese Medicine May 13 investor relations activities log table, in an interview with the research company said that this year the concentration of superior resources to promote Xinkeshu tablets, capsules Gushukang / particle , Hedan tablets / capsules, oral solution cerebral blood thinning four pillars of product sales revenue growth, steady growth in sales of other products, rapid profit growth, while looking for the right opportunity to products or mergers and acquisitionsFor mergers and acquisitions direction, the company said, will always focus on the field of traditional Chinese medicine, deep plowing fields broken down, widening deepen "moat", capital operation will also focus on the field of traditional Chinese medicine, choose through mergers and acquisitions introduce an exclusive product, attract talent, reduce marketing costs , rapid increase in sales revenues and profits, expand the sharing of resources, synergies spaceperformance of traditional Chinese medicine industry companies Pharmaceutical Nakasone held briefing session also attracted a large number of institutionsCompanies in the survey said the company has developed a targeted response measures, and has provided supplies and vaccination more convenient and safe travel program some researchers and subjectsSo far, clinical trials in accordance with the basic plan on scheduleIn addition, Nakasone Pharmaceutical responsible person in the performance of online briefings, said the company strategy in the biopharmaceutical field include "to target new" and "faster." The company's strength lies: a successful Compaq Sipp R & D experience, the company will continue to develop this idea, competition and comparison with original mechanism of cold or make new molecular targets; Compaq Sipp performance in the field of ophthalmology win the ophthalmic industry experts, doctors agreed, Nakasone has become China's well-known brands of Ophthalmology, the company will continue to develop innovative biological medicine in this field; R & D team to form new advantages in the development of new drugs and new molecular mechanism, you can We look forward to the future the company will have a new biological innovative drugs to market Meanwhile, the company in terms of commercial production and global multi-center clinical trials of drugs and other protein molecules have accumulated a wealth of experience, the company formed its own advantage, a good foundation for the subsequent development of biological drugs and get to market quickly laid.